Acrux heads to the Finnish
Thursday, 14 August, 2008
Acrux [ASX: ACR] has entered into a manufacturing alliance with the Finnish Orion Corporation.
Under the agreement, Orion will become the exclusive manufacturer for Acrux's Testosterone MD-Lotion, as well as a range of transdermal spray products under development.
Acrux retains the rights to supply the products to licensees in all territories.
Both parties will invest in additional equipment at Orion's manufacturing facility as part of the alliance.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
